CXCL13 and acute lymphoblastic leukemia: With respect to hematological cancers, specifically, B cell chronic lymphocytic leukemia (B-CLL) and acute lymphocytic leukemia (B-ALL), there is significant evidence that CXCL13 drives pro-growth and survival signaling (78, 79).